General Information of Drug Off-Target (DOT) (ID: OT6W8CWP)

DOT Name Protein transport protein Sec24B (SEC24B)
Synonyms SEC24-related protein B
Gene Name SEC24B
Related Disease
Neural tube defect ( )
Pneumocystis pneumonia ( )
UniProt ID
SC24B_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
3EH1
Pfam ID
PF00626 ; PF08033 ; PF04815 ; PF04811 ; PF04810
Sequence
MSAPAGSSHPAASARIPPKFGGAAVSGAAAPAGPGAGPAPHQQNGPAQNQMQVPSGYGLH
HQNYIAPSGHYSQGPGKMTSLPLDTQCGDYYSALYTVPTQNVTPNTVNQQPGAQQLYSRG
PPAPHIVGSTLGSFQGAASSASHLHTSASQPYSSFVNHYNSPAMYSASSSVASQGFPSTC
GHYAMSTVSNAAYPSVSYPSLPAGDTYGQMFTSQNAPTVRPVKDNSFSGQNTAISHPSPL
PPLPSQQHHQQQSLSGYSTLTWSSPGLPSTQDNLIRNHTGSLAVANNNPTITVADSLSCP
VMQNVQPPKSSPVVSTVLSGSSGSSSTRTPPTANHPVEPVTSVTQPSELLQQKGVQYGEY
VNNQASSAPTPLSSTSDDEEEEEEDEEAGVDSSSTTSSASPMPNSYDALEGGSYPDMLSS
SASSPAPDPAPEPDPASAPAPASAPAPVVPQPSKMAKPFGYGYPTLQPGYQNATAPLISG
VQPSNPVYSGFQQYPQQYPGVNQLSSSIGGLSLQSSPQPESLRPVNLTQERNILPMTPVW
APVPNLNADLKKLNCSPDSFRCTLTNIPQTQALLNKAKLPLGLLLHPFRDLTQLPVITSN
TIVRCRSCRTYINPFVSFIDQRRWKCNLCYRVNDVPEEFMYNPLTRSYGEPHKRPEVQNS
TVEFIASSDYMLRPPQPAVYLFVLDVSHNAVEAGYLTILCQSLLENLDKLPGDSRTRIGF
MTFDSTIHFYNLQEGLSQPQMLIVSDIDDVFLPTPDSLLVNLYESKELIKDLLNALPNMF
TNTRETHSALGPALQAAFKLMSPTGGRVSVFQTQLPSLGAGLLQSREDPNQRSSTKVVQH
LGPATDFYKKLALDCSGQQTAVDLFLLSSQYSDLASLACMSKYSAGCIYYYPSFHYTHNP
SQAEKLQKDLKRYLTRKIGFEAVMRIRCTKGLSMHTFHGNFFVRSTDLLSLANINPDAGF
AVQLSIEESLTDTSLVCFQTALLYTSSKGERRIRVHTLCLPVVSSLADVYAGVDVQAAIC
LLANMAVDRSVSSSLSDARDALVNAVVDSLSAYGSTVSNLQHSALMAPSSLKLFPLYVLA
LLKQKAFRTGTSTRLDDRVYAMCQIKSQPLVHLMKMIHPNLYRIDRLTDEGAVHVNDRIV
PQPPLQKLSAEKLTREGAFLMDCGSVFYIWVGKGCDNNFIEDVLGYTNFASIPQKMTHLP
ELDTLSSERARSFITWLRDSRPLSPILHIVKDESPAKAEFFQHLIEDRTEAAFSYYEFLL
HVQQQICK
Function
Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex. Plays a central role in cargo selection within the COPII complex and together with SEC24A may have a different specificity compared to SEC24C and SEC24D. May package preferentially cargos with cytoplasmic DxE or LxxLE motifs and may also recognize conformational epitopes.
KEGG Pathway
Protein processing in endoplasmic reticulum (hsa04141 )
Pathogenic Escherichia coli infection (hsa05130 )
Reactome Pathway
COPII-mediated vesicle transport (R-HSA-204005 )
MHC class II antigen presentation (R-HSA-2132295 )
Cargo concentration in the ER (R-HSA-5694530 )
SARS-CoV-2 activates/modulates innate and adaptive immune responses (R-HSA-9705671 )
Antigen Presentation (R-HSA-983170 )
Regulation of cholesterol biosynthesis by SREBP (SREBF) (R-HSA-1655829 )

Molecular Interaction Atlas (MIA) of This DOT

2 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neural tube defect DIS5J95E Definitive Genetic Variation [1]
Pneumocystis pneumonia DISFSOM3 Limited Genetic Variation [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Protein transport protein Sec24B (SEC24B). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Protein transport protein Sec24B (SEC24B). [12]
------------------------------------------------------------------------------------
13 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Protein transport protein Sec24B (SEC24B). [4]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Protein transport protein Sec24B (SEC24B). [5]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Protein transport protein Sec24B (SEC24B). [6]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide increases the expression of Protein transport protein Sec24B (SEC24B). [7]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Protein transport protein Sec24B (SEC24B). [8]
Selenium DM25CGV Approved Selenium decreases the expression of Protein transport protein Sec24B (SEC24B). [9]
Menadione DMSJDTY Approved Menadione affects the expression of Protein transport protein Sec24B (SEC24B). [8]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Protein transport protein Sec24B (SEC24B). [10]
Dihydrotestosterone DM3S8XC Phase 4 Dihydrotestosterone increases the expression of Protein transport protein Sec24B (SEC24B). [11]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide increases the expression of Protein transport protein Sec24B (SEC24B). [13]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Protein transport protein Sec24B (SEC24B). [14]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Protein transport protein Sec24B (SEC24B). [15]
KOJIC ACID DMP84CS Investigative KOJIC ACID increases the expression of Protein transport protein Sec24B (SEC24B). [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)

References

1 Mutations in the COPII vesicle component gene SEC24B are associated with human neural tube defects.Hum Mutat. 2013 Aug;34(8):1094-101. doi: 10.1002/humu.22338. Epub 2013 May 13.
2 Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b.Development. 2010 Apr;137(7):1067-73. doi: 10.1242/dev.041434.
3 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
4 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
5 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
6 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
7 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
8 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
9 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
10 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
11 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
12 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
13 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
14 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
15 Gene expression changes in primary human nasal epithelial cells exposed to formaldehyde in vitro. Toxicol Lett. 2010 Oct 5;198(2):289-95.
16 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.